Mylan, the giant pharmaceutical company, has gotten tons of grief lately for jacking up the price of its lifesaving EpiPen. Millions of American families, including mine, carry Epis to protect against anaphylactic shock, which can seemingly come out of nowhere and kill someone remarkably quickly.

No, this isn’t going to be yet another rant against Mylan for gouging people, governments, insurance companies and employers by raising EpiPen prices in order to enhance its bottom line and provide bigger paydays for its executives.

Instead, I’d like to show you how EpiPen pricing highlights the un-American behavior of Mylan and its fellow corporate deserters, which people more polite than I call “corporate inverters.”

Mylan Inc., based in suburban Pittsburgh, became Netherlands-based Mylan N.V. last year in order to reduce its U.S. income taxes. But when you take a close look at Mylan’s business, you see that the company depends heavily on U.S. government services both to make Epis mega-profitable and to funnel profits out of our country to reduce its income tax bill here. Read more.

---

---